Centessa Pharmaceuticals
役員
19人の主要幹部と一緒に組織図を見る
Centessa Pharmaceuticalsでもっとも検索された略歴
- Saurabh Saha, Chief Executive Officer and Director
- Francesco De Rubertis, Chairman of The Board
- Mary Hedley, Director
更新履歴 - ％sの
- Ellie Imは、Senior Vice President of Clinical Development, Oncologyとして加わりました (2023年10月3日公開されたニュース).
- April Dovholukは、Senior Vice President of Development Operationsとして加わりました (2023年10月3日公開されたニュース).
アラートを作成
Centessa Pharmaceuticals のエグゼクティブの異動をフォローします。
医薬品
Centessa PharmaceuticalsはPfizer (アメリカ合衆国（米国）),Sanofi (フランス共和国),Johnson & Johnson (アメリカ合衆国（米国）)を含む1,861の競合企業を有します。
Popular M&A news in 医薬品
- MedMen has filed for bankruptcy protection (2024年4月28日に公開).
- AstraZeneca has announced the acquisition of Fusion Pharma (2024年3月23日に公開).
- AstraZeneca has announced the acquisition of Amolyt Pharma (2024年3月19日に公開).
医薬品業界でのその他のコンタクトの提案
ニュース
％sによる最新のプレスリリース
- Centessa Pharmaceuticals Announces Addition of Harris L. Rotman, PhD, as Senior Vice President of Regulatory Affairs | Centessa Pharmaceuticals
- Centessa Pharmaceuticals Announces Appointment of Dr. Mathias Hukkelhoven to its Board of Directors | Centessa Pharmaceuticals
- Centessa Pharmaceuticals to Participate in Upcoming Investor Conferences | Centessa Pharmaceuticals
- Centessa Pharmaceuticals Announces Poster Presentation of First Preclinical Data for LockBody® Program at 2022 ASCO Annual Meeting | Centessa Pharmaceuticals
- Centessa Pharmaceuticals Makes Strategic Decision to Discontinue Clinical Development of Lixivaptan for Autosomal Dominant Polycystic Kidney Disease (ADPKD) | Centessa Pharmaceuticals
- Centessa Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Business Updates | Centessa Pharmaceuticals
- Centessa Pharmaceuticals Doses First Subject in Global Phase 3 ACTION Study of Lixivaptan in Autosomal Dominant Polycystic Kidney Disease | Centessa Pharmaceuticals
- Centessa Pharmaceuticals Reports Fourth Quarter and 2021 Financial Results and Provides Business Update | Centessa Pharmaceuticals
- Centessa Pharmaceuticals Expands Management Team and Adds to Extensive Development Expertise | Centessa Pharmaceuticals
- Centessa Pharmaceuticals to Present at the Guggenheim Genomic Medicines & Rare Disease Day | Centessa Pharmaceuticals
- View more press releases Close
％sについてのソーシャルメディア
- Centessa Pharmaceuticals についてのウィキペディア,Google News & Yahoo Financeの記事
- Centessa Pharmaceuticals についてのLinkedIn,ツイッター & YouTubeの記事
